Shirong Li

Dr. Shirong Li


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 April 2023 in Molecules
Verified
Journal Article
Open access
PDF file
MLMingfei Liu
Mingfei Liu
YWYuxuan Wang
Yuxuan Wang
HXHaixin Xiang
Haixin Xiang
MGMeng Guo
Meng Guo
SLShirong Li
Shirong Li
JYJingchun Yao
Jingchun Yao
Ulcerative colitis (UC) has attracted much attention for its negative influence on quality of life and increased risk of colorectal cancer. Chemical and biological drugs are currently the usual treatment for UC. These drugs always induce severe side effects, or patients might become resistant to these therapies. Therefore, new therapeutic options for UC are urgently needed. In this study, we discovered the inhibitory activity of the intestinal tryptophan metabolite indole-3-carboxaldehyde (3-IAld) in dextran sulfate sodium salt (DSS)-induced UC mice by targeting the TLR4/NF-κB/p38 signaling pathway. This compound effectively protected against colon length shortening and damage induced by DSS in the colon, notably reducing the severity of inflammation. The production of inflammatory factors of TNF-α, IL-6, and IL-1β was significantly attenuated when treating with 3-IAld in vivo and vitro. This might be attributed to inhibition of the TLR4/NF-kB/p38 signaling pathway. Moreover, 3-IAld could up-regulate the expression of ZO-1 and Occludin in vivo and vitro. Meanwhile, liquid chromatography mass spectrometry (LC-MS) results showed that 3-IAld could balance the aspartate and glutamate metabolism and the lysine degradation metabolism in the serum of DSS-induced colitis mice. In conclusion, 3-IAld ameliorated the intestinal barrier dysfunction and inflammatory response in DSS-induced UC mice, balanced amino acid metabolism, and inhibited the activation of the TLR4/NF-kB/p38 signaling pathway, thereby protecting mice with colitis.


28 December 2023 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
SLShirong Li
Shirong Li
HXHe Xiao
He Xiao
MLMingfei Liu
Mingfei Liu
QWQingguo Wang
Qingguo Wang
CSChenghong Sun
Chenghong Sun
XXXuefeng Xiao
Xuefeng Xiao

13 July 2024 in International Immunopharmacology
Verified
Journal Article
Closed access
MLMingfei Liu
Mingfei Liu
YZYuanyuan Zhang
Yuanyuan Zhang
LDLinkui Deng
Linkui Deng
LPLihong Pan
Lihong Pan
XLXiaoyan Lu
Xiaoyan Lu
JYJingchun Yao
Jingchun Yao

6 April 2025 in Journal of Ethnopharmacology
Verified
Journal Article
Closed access
HTHongguang Tang
Hongguang Tang
WNWenting Ni
Wenting Ni
DNDejun Niu
Dejun Niu
KWKun Wang
Kun Wang
MSMengmeng Shen
Mengmeng Shen
YZYue Zhou
Yue Zhou

6 December 2024 in Journal of Pharmaceutical and Biomedical Analysis
Verified
Journal Article
Closed access
SLShirong Li
Shirong Li
MLMingfei Liu
Mingfei Liu
LPLihong Pan
Lihong Pan
QFQun Feng
Qun Feng
XLXiaoyan Lu
Xiaoyan Lu
XXXuefeng Xiao
Xuefeng Xiao